It’s research that could lead to everything from the development of drugs to treat aging diseases in babies to the redesign of HIV medications to lessen their side effects.
Sounds like a stretch, right?
But it’s true. Scientists have discovered that defects in a certain protein (Ste24p) can lead to a range of issues, including several progerias, a group of very rare but devastating conditions that cause young children to age quickly and die prematurely.
This protein also interacts with antiretroviral therapies and relates to a group of diseases that includes muscular dystrophy. Looking at this protein could even help us understand the overall aging process.
Go in-depth on the details of this research and all its possible future implications.